Related Experiment Video
Updated: Nov 17, 2025
06:52
Fabrication of Amyloid-β-Secreting Alginate Microbeads for Use in Modelling Alzheimer's Disease
Published on: July 6, 2019
9.5K
Remodeling Alzheimer-amyloidosis models by seeding
Brittany S Ulm1, David R Borchelt1, Brenda D Moore2
1Department of Neuroscience, Center for Translational Research in Neurodegenerative Disease, McKnight Brain Institute, College of Medicine, University of Florida, Gainesville, FL, USA.
Molecular Neurodegeneration
|February 16, 2021
Summary
Alzheimer's disease research uses transgenic mouse models to study amyloid beta pathology. Seeding methods influence amyloid deposit characteristics and disease onset, offering insights for therapeutic development.
Area of Science:
- Neurodegenerative diseases
- Alzheimer's disease research
- Transgenic animal models
Background:
- Alzheimer's disease (AD) is a prevalent neurodegenerative disorder characterized by amyloid beta plaques and tau tangles.
- Transgenic mouse models are crucial tools for replicating AD pathology and advancing research.
- Familial AD is linked to mutations in amyloid precursor protein and presenilins.
Purpose of the Study:
- To review factors influencing amyloid beta pathology seeding in transgenic models.
- To understand how seeding methods impact amyloid deposit morphology and disease onset.
- To provide insights for improving Alzheimer's disease research models.
Main Methods:
- Review of existing literature on amyloid beta seeding in transgenic mouse models.
- Analysis of factors affecting amyloid pathology development post-seeding.
- Discussion of seed source, incubation time, host genetics, and inoculum preparation.
Main Results:
- Seeding methods significantly alter amyloid deposit morphology.
- The timing of pathology development is influenced by seeding parameters.
- Transgenic host characteristics and inoculum preparation are key variables.
Conclusions:
- Understanding seeding factors is critical for refining Alzheimer's disease models.
- Optimized seeding techniques can enhance the utility of transgenic mice for AD research.
- Further investigation into seeding mechanisms may reveal therapeutic targets.
